US Bancorp’s Acura Pharmaceuticals ACUR Stock Holding History

US Bancorp’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-100	Closed	–	–	3688
2014 Q3	$0	Buy	+100	New	+$469	﹤0.01%	3623

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RIL

Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FWP

FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

US Bancorp's ACUR Position: Q4 2014 in Review

US Bancorp sold out of Acura Pharmaceuticals (ACUR) in Q4 2014, closing a stake of 100 shares.

US Bancorp first reported a position in ACUR in Q3 2014 and held it in 1 quarter. The position peaked at $0 in Q3 2014. 33 funds tracked by Wall St. Rank hold ACUR as of Q4 2014.

US Bancorp reported no remaining Acura Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
US Bancorp sold 100 Acura Pharmaceuticals shares in Q4 2014.
US Bancorp first reported a position in Acura Pharmaceuticals in Q3 2014 and held it in 1 quarter.
US Bancorp's Acura Pharmaceuticals position peaked at $0 in Q3 2014.
33 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q4 2014.

Based on US Bancorp's 13F filing for Q4 2014, filed 13 Feb 2015.